SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-232026
Filing Date
2023-09-11
Accepted
2023-09-11 08:18:29
Documents
14
Period of Report
2023-09-11
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d528926d8k.htm   iXBRL 8-K 34652
2 EX-99.1 d528926dex991.htm EX-99.1 11081
6 GRAPHIC g528926g0909025819167.jpg GRAPHIC 2712
  Complete submission text file 0001193125-23-232026.txt   178760

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230911.xsd EX-101.SCH 2526
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230911_lab.xml EX-101.LAB 17945
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230911_pre.xml EX-101.PRE 11236
8 EXTRACTED XBRL INSTANCE DOCUMENT d528926d8k_htm.xml XML 3442
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 231246745
SIC: 2834 Pharmaceutical Preparations